查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589095

消費者保健市場：依產品、分佈 - 2025-2030 年全球預測

Consumer Healthcare Market by Product (Dietary Supplements, OTC Pharmaceuticals), Distribution (Departmental Stores, Independent Retailers, Pharmacies or Drugstores) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年消費者醫療保健市場規模為3,330.3億美元，預估2024年將達3,569.4億美元，複合年成長率為7.38%，2030年將達5,483.1億美元。

消費者醫療保健是醫療保健產業中一個快速發展的領域，包括健康產品、成藥、營養食品和消費者為自我護理而購買的個人護理用品。健康意識的提高、慢性病盛行率的上升、人口老化以及減輕傳統醫療保健服務負擔的自我自我治療趨勢推動了消費者醫療保健的需求。消費保健品應用廣泛，包括預防保健、疾病管理、營養食品和個人保健等，最終用途是尋求便捷健康解決方案的個人家庭和零售消費者。關鍵的成長要素包括產品配方的技術進步、消費者數位健康素養的提高以及向整體健康和保健方法的轉變。利用數位平台的直接面對消費者和個人化健康解決方案存在機會。透過與電子商務巨頭的策略聯盟以及投資資料分析以增強消費者洞察力，還有擴大市場覆蓋範圍的潛力。然而，挑戰包括監管障礙、價格敏感性以及來自學名藥藥和自有品牌藥物的激烈競爭，這些可能會阻礙成長。公司還需要意識到線上健康領域可能產生的錯誤訊息，這會影響消費者的信任。個人化營養、遠端醫療和人工智慧健康監測等領域的創新可以提供競爭優勢。隨著消費者日益要求環保責任，您還可以探索永續和環保的產品線。市場動態是動態的並且以消費者為中心，並且越來越重視便利性和可及性。保持敏捷性並響應不斷變化的消費者偏好和技術趨勢對於在這個快速成長的市場中實現持續成長和成功至關重要。該研究的建議包括投資於研發以保持領先於新的健康趨勢，並努力提高產品資訊的透明度以建立消費者的信任。

主要市場統計
基準年[2023] 3330.3億美元
預測年份 [2024] 3569.4億美元
預測年份 [2030] 5483.1億美元
複合年成長率（%） 7.38%

市場動態：揭示快速發展的消費者醫療保健市場的關鍵市場洞察

供需的動態交互作用正在改變消費者醫療保健市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 老年人口的增加和消費者對自我治療產品的傾向
    • 政府支持改善獲得負擔得起的醫療保健的機會
    • 擴大自有品牌產品的採用消費者醫療保健
  • 市場限制因素
    • 缺乏活性成分的仿冒品的可用性
  • 市場機會
    • 提高健康和預防藥物的核准率
    • 線上藥局的快速成長和透過線上平台增加的可得性
  • 市場挑戰
    • 對消費者保健產品濫用和誤用的擔憂

波特五力：駕馭消費者醫療保健市場的策略工具

波特的五力架構是了解消費者醫療保健市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解消費保健市場的外部影響

外部宏觀環境因素在塑造消費者醫療保健市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解消費保健市場的競爭狀況

對消費者醫療保健市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 消費者醫療保健市場定位矩陣供應商績效評估

FPNV定位矩陣是評估消費者醫療保健市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製消費者保健市場的成功之路

對於希望加強在全球市場的影響力的公司來說，消費者醫療保健市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人口老化加劇和自我治療產品的消費趨勢
      • 政府支持提供負擔得起的、改善的醫療保健服務
      • 自有品牌消費者保健產品的採用率增加
    • 抑制因素
      • 分銷不含活性藥物成分的仿冒品
    • 機會
      • 提高保健和預防藥物的核准率
      • 線上藥局的快速成長和透過線上平台增加的可用性
    • 任務
      • 對消費者保健產品濫用和誤用的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章消費保健市場：依產品分類

  • 食品補充品
  • 非處方藥

第7章消費保健市場經銷商

  • 百貨公司
  • 獨立零售商
  • 藥房或藥局
  • 專業零售商
  • 超級市場或大賣場

第8章美洲消費保健市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區消費保健市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲消費保健市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • SPE Capital 收購突尼斯領先營養食品公司 Vital 的多數股權
    • Nutrilitius 透過推出新型營養食品擴大了其產品組合，釋放了食品科學與技術的力量。
    • LBB Specialties 與帝斯曼宣佈在北美食品補充劑分銷領域建立合作夥伴關係
    • Cosmos Health 透過亞馬遜和 eBay 在德國和奧地利推出 Sky Premium Life 營養食品
    • 保健補充品：塔塔消費者進入保健補充品領域並推出植物蛋白粉
    • Cipla Health 收購營養食品品牌“Endura Mass”
    • Orkla Health 收購 Healthspan
    • 安麗印度推出軟糖和果凍條營養食品
    • Wellbeing Nutrition 融資 220 萬美元，由 Fireside Ventures主導
    • 拜耳在印度設立消費者健康部門
  • 戰略分析和建議

公司名單

  • Abbott Laboratories Inc.
  • Alembic Pharmaceuticals Ltd.
  • Alkem Laboratories Limited
  • AMCO Proteins
  • American Health Inc.
  • Amway Corporation by Alticor corporation
  • Axtria Inc.
  • BASF SE
  • Bayer AG
  • Bionova Lifesciences by Pragati Biocare Pvt. Ltd.
  • Boehringer Ingelheim International GmbH
  • Cipla, Inc.
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • Endo Pharmaceuticals PLC by DuPont de Nemours, Inc.
  • Gemini Pharmaceuticals Inc.
  • Glanbia PLC
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Ltd.
  • Henin Lukinz Pvt. Ltd.
  • Herbalife Ltd.
  • Hetero Drugs Ltd.
  • Himalaya Wellness Company
  • Iovate Health Sciences International Inc.
  • Ipsen SA
  • Johnson & Johnson Services, Inc.
  • Koninklijke DSM NV
  • Lonza Group Ltd.
  • Lupin Limited
  • Mankind Pharma
  • MusclePharm Corporation
  • Mylan Pharmaceuticals Pvt. Ltd. by Viatris
  • Nature's Bounty, Inc. by Nestle SA
  • Novartis AG
  • Omega Protein Corporation
  • Pfizer Inc.
  • Piramal Group
  • Procter & Gamble Company
  • PureTek Corporation
  • QuestNutrition
  • Reckitt Benckiser Group PLC
  • Sanofi SA
  • Sun Pharmaceutical Industries Limited
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Ventus Pharmaceuticals Private Limited
  • Zoic Biotech Private Limited
Product Code: MRR-433AB1DC291F

The Consumer Healthcare Market was valued at USD 333.03 billion in 2023, expected to reach USD 356.94 billion in 2024, and is projected to grow at a CAGR of 7.38%, to USD 548.31 billion by 2030.

Consumer healthcare is a rapidly evolving segment of the healthcare industry, encompassing wellness products, OTC drugs, dietary supplements, and personal care items that consumers purchase for self-care. The necessity for consumer healthcare is driven by the increasing health awareness, rising prevalence of chronic diseases, an aging population, and a trend towards self-medication which reduces the burden on traditional healthcare services. The application of consumer healthcare products spans across preventive care, disease management, nutritional supplementations, and personal wellness, with end-use in individual households and retail consumers seeking convenient health solutions. Key growth influencers include technological advancements in product formulations, increased digital health literacy among consumers, and a shift towards holistic health and wellness approaches. Opportunities exist in leveraging digital platforms for direct-to-consumer sales and personalized health solutions. Furthermore, there's potential in expanding market reach through strategic partnerships with e-commerce giants and investing in data analytics to enhance consumer insights. However, challenges include regulatory hurdles, price sensitivity, and intense competition from generic and private-label brands, which may hinder growth. Companies should also be wary of misinformation that can arise from online health spaces, affecting consumer trust. Innovating in areas such as personalized nutrition, telehealth, and AI-driven health monitoring can offer competitive advantages, as can exploring sustainable and eco-friendly product lines in response to growing consumer demand for environmental responsibility. The nature of the consumer healthcare market is dynamic and consumer-centric, with an increasing emphasis on convenience and accessibility. Staying agile and responsive to changing consumer preferences and technological trends will be critical for sustained growth and success in this burgeoning market. Recommendations include investing in research and development to stay ahead of emerging health trends and committing to transparency in product information to build consumer trust.

KEY MARKET STATISTICS
Base Year [2023] USD 333.03 billion
Estimated Year [2024] USD 356.94 billion
Forecast Year [2030] USD 548.31 billion
CAGR (%) 7.38%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Consumer Healthcare Market

The Consumer Healthcare Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising geriatric population and inclination of consumers towards self-medication products
    • Government support to offer affordable and improved access to healthcare
    • Growing adoption of private labels consumer healthcare products
  • Market Restraints
    • Availability of counterfeit products that lack active pharmaceutical ingredients
  • Market Opportunities
    • Increasing approval rate of wellness and preventive medicines
    • Rapid growth of online pharmacies and improved availability through online platforms
  • Market Challenges
    • Concerns associated with abuse and misuse of consumer healthcare products

Porter's Five Forces: A Strategic Tool for Navigating the Consumer Healthcare Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Consumer Healthcare Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Consumer Healthcare Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Consumer Healthcare Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Consumer Healthcare Market

A detailed market share analysis in the Consumer Healthcare Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Consumer Healthcare Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Consumer Healthcare Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Consumer Healthcare Market

A strategic analysis of the Consumer Healthcare Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Consumer Healthcare Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Inc., Alembic Pharmaceuticals Ltd., Alkem Laboratories Limited, AMCO Proteins, American Health Inc., Amway Corporation by Alticor corporation, Axtria Inc., BASF SE, Bayer AG, Bionova Lifesciences by Pragati Biocare Pvt. Ltd., Boehringer Ingelheim International GmbH, Cipla, Inc., Dr. Reddy's Laboratories, Eli Lilly and Company, Endo Pharmaceuticals PLC by DuPont de Nemours, Inc., Gemini Pharmaceuticals Inc., Glanbia PLC, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Henin Lukinz Pvt. Ltd., Herbalife Ltd., Hetero Drugs Ltd., Himalaya Wellness Company, Iovate Health Sciences International Inc., Ipsen S.A., Johnson & Johnson Services, Inc., Koninklijke DSM N.V., Lonza Group Ltd., Lupin Limited, Mankind Pharma, MusclePharm Corporation, Mylan Pharmaceuticals Pvt. Ltd. by Viatris, Nature's Bounty, Inc. by Nestle S.A., Novartis AG, Omega Protein Corporation, Pfizer Inc., Piramal Group, Procter & Gamble Company, PureTek Corporation, QuestNutrition, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Limited, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Ventus Pharmaceuticals Private Limited, and Zoic Biotech Private Limited.

Market Segmentation & Coverage

This research report categorizes the Consumer Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Dietary Supplements and OTC Pharmaceuticals.
  • Based on Distribution, market is studied across Departmental Stores, Independent Retailers, Pharmacies or Drugstores, Specialist Retailers, and Supermarkets or Hypermarkets.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising geriatric population and inclination of consumers towards self-medication products
      • 5.1.1.2. Government support to offer affordable and improved access to healthcare
      • 5.1.1.3. Growing adoption of private labels consumer healthcare products
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of counterfeit products that lack active pharmaceutical ingredients
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing approval rate of wellness and preventive medicines
      • 5.1.3.2. Rapid growth of online pharmacies and improved availability through online platforms
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with abuse and misuse of consumer healthcare products
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Consumer Healthcare Market, by Product

  • 6.1. Introduction
  • 6.2. Dietary Supplements
  • 6.3. OTC Pharmaceuticals

7. Consumer Healthcare Market, by Distribution

  • 7.1. Introduction
  • 7.2. Departmental Stores
  • 7.3. Independent Retailers
  • 7.4. Pharmacies or Drugstores
  • 7.5. Specialist Retailers
  • 7.6. Supermarkets or Hypermarkets

8. Americas Consumer Healthcare Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Consumer Healthcare Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Consumer Healthcare Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. SPE Capital acquires majority stake in Vital, the leading nutritional supplements company in Tunisia
    • 11.3.2. Nutrilitius expands portfolio with launch of new range of nutraceuticals, Unleashing the Power of Food Science & Technology
    • 11.3.3. LBB Specialties and DSM announce partnership for North America Dietary Supplements Distribution
    • 11.3.4. Cosmos Health to Launch Sky Premium Life Nutritional Supplement Products in Germany and Austria via Amazon and Ebay
    • 11.3.5. health supplements: Tata Consumer enters health supplements segment, launches plant protein powder
    • 11.3.6. Cipla Health to buy nutritional supplement brand Endura Mass
    • 11.3.7. Orkla Health acquires Healthspan
    • 11.3.8. Amway India launches nutrition supplements in gummies and jelly strips
    • 11.3.9. Wellbeing Nutrition raises $2.2 million led by Fireside Ventures
    • 11.3.10. Bayer launches Consumer Health division in India
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories Inc.
  • 2. Alembic Pharmaceuticals Ltd.
  • 3. Alkem Laboratories Limited
  • 4. AMCO Proteins
  • 5. American Health Inc.
  • 6. Amway Corporation by Alticor corporation
  • 7. Axtria Inc.
  • 8. BASF SE
  • 9. Bayer AG
  • 10. Bionova Lifesciences by Pragati Biocare Pvt. Ltd.
  • 11. Boehringer Ingelheim International GmbH
  • 12. Cipla, Inc.
  • 13. Dr. Reddy's Laboratories
  • 14. Eli Lilly and Company
  • 15. Endo Pharmaceuticals PLC by DuPont de Nemours, Inc.
  • 16. Gemini Pharmaceuticals Inc.
  • 17. Glanbia PLC
  • 18. GlaxoSmithKline PLC
  • 19. Glenmark Pharmaceuticals Ltd.
  • 20. Henin Lukinz Pvt. Ltd.
  • 21. Herbalife Ltd.
  • 22. Hetero Drugs Ltd.
  • 23. Himalaya Wellness Company
  • 24. Iovate Health Sciences International Inc.
  • 25. Ipsen S.A.
  • 26. Johnson & Johnson Services, Inc.
  • 27. Koninklijke DSM N.V.
  • 28. Lonza Group Ltd.
  • 29. Lupin Limited
  • 30. Mankind Pharma
  • 31. MusclePharm Corporation
  • 32. Mylan Pharmaceuticals Pvt. Ltd. by Viatris
  • 33. Nature's Bounty, Inc. by Nestle S.A.
  • 34. Novartis AG
  • 35. Omega Protein Corporation
  • 36. Pfizer Inc.
  • 37. Piramal Group
  • 38. Procter & Gamble Company
  • 39. PureTek Corporation
  • 40. QuestNutrition
  • 41. Reckitt Benckiser Group PLC
  • 42. Sanofi S.A.
  • 43. Sun Pharmaceutical Industries Limited
  • 44. Takeda Pharmaceutical Company Limited
  • 45. Teva Pharmaceutical Industries Ltd.
  • 46. Ventus Pharmaceuticals Private Limited
  • 47. Zoic Biotech Private Limited

LIST OF FIGURES

  • FIGURE 1. CONSUMER HEALTHCARE MARKET RESEARCH PROCESS
  • FIGURE 2. CONSUMER HEALTHCARE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CONSUMER HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CONSUMER HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONSUMER HEALTHCARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONSUMER HEALTHCARE MARKET DYNAMICS
  • TABLE 7. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY OTC PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DEPARTMENTAL STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY INDEPENDENT RETAILERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PHARMACIES OR DRUGSTORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY SPECIALIST RETAILERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY SUPERMARKETS OR HYPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 102. CONSUMER HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. CONSUMER HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023